sign up log in
Want to go ad-free? Find out how, here.

Infratil sharpens focus on data centres and renewable energy following jump in half-year earnings, lifts full-year earnings guidance

Business / news
Infratil sharpens focus on data centres and renewable energy following jump in half-year earnings, lifts full-year earnings guidance
dc
Ismail Enes Ayhan on Unsplash.

Infrastructure investment company Infratil has reported an increase of more than $150 million in its half-year earnings, driven by growth in its data centre and renewable energy investments.

Infratil released its financial results for the six months ending September on Wednesday.

Total operating earnings for this period, or EBITDAF (earnings before interest, tax, depreciation, amortisation, and fair value adjustments), came to $711 million, up 28%, or $156 million, compared to the previous half-year period last year.

Infratil had $1.4 billion of available liquidity as of September 30, supported by its BBB+ credit rating. The company said its balance sheet is “well positioned” to keep funding portfolio growth opportunities.

The company’s portfolio asset value rose 8% to $22.3 billion in the six months to September 30, up $1.7 billion from the previous corresponding period last year.

Infratil said strong growth in data centre business CDC drove the increase in its $711 million EBITDAF, alongside higher contributions from One New Zealand in telecommunications and Longroad Energy in renewable energy.

Infratil holds a 49.7% stake in CDC, the largest privately owned and operated data centre business across Australia and NZ, owns 99.8% of One NZ and holds a 42% stake in US renewable energy developer Longroad.

A net parent loss of NZ$248 million was recorded for Infratil’s half-year period, due to a “large increase” in CDC’s equity valuation, according to Infratil. This drove a $256 million accounting provision for incentive fees, although the quantum of any fees remains subject to equity valuations at year-end.

During the six months to September, CDC delivered another 90 megawatts (MW) of operating capacity and Longroad delivered almost 600 MW, according to Infratil Chief Executive Jason Boyes.

“The earnings momentum from their construction programmes is accelerating, with another 810MW of data centre capacity and 2GW of contracted power capacity under construction,” he said.

“CDC and Longroad are well placed to capture continued demand for data centres and energy. Both have extensive development pipelines, strong access to capital and established track records of working with communities and securing approvals. Those capabilities are becoming increasingly valuable as regulatory complexity and tighter funding markets make it harder for the wider industry to deliver this infrastructure.”

‘Sharpening focus’

CDC's EBITDAF in the latest half-year results came to A$339 million (NZ$415.3 million) and was up 84% year-on-year, with 350MW of capacity deployed in its data centres.

Infratil said contracted capacity grew to 1.1 gigawatts (GW), with 625MW of new contracts signed during the half. Once fully deployed, this is expected to deliver annualised EBITDAF of A$2.2 billion, according to Infratil.

CDC had 810MW of capacity under construction across multiple sites at September 30.

Longroad’s EBITDAF increased 10% from the prior half-year period, to US$91 million (NZ$165.6 million), as its operating renewable energy capacity grew to 4.2GW.

Infratil said two solar projects totalling almost 600MW were completed in the six months to September 30. Longroad expects operating and in-construction capacity to exceed 14GW by the end of 2029, lifting its operating fleet run-rate EBITDAF to around US$1.2 billion (NZ$2.2 billion).

Infratil said it is “sharpening its focus” on tackling growing infrastructure and energy needs, including opportunities to bring together “complementary capabilities” across its portfolio.

“Rather than looking for an entirely new large investment sector, our near-term focus is on capturing more value from the positions we already have in data centres and renewable energy,” Boyes said.

He used the example of CDC and Contact Energy investigating a 250MW data centre development in Stratford, New Zealand that was announced in August. The proposed data centre will be based in Stratford and supported by co-located battery storage development. It will be built near the site of Contact’s Taranaki Combined Cycle gas power plant (TCC), which was decommissioned earlier this year.

Mixed results

Boyes said One NZ and Wellington Airport (Infratil holds a 66% stake in the airport) had also performed well in “difficult conditions” during the six months to September.

One NZ’s half-year earnings were up 10% to $325 million, which Infratil said was backed by a 25,000 increase in postpay mobile connections and the intellectual property sale of a network platform it developed.

Wellington Airport’s EBITDAF was flat at $66 million. Infratil said the Airport achieved this result despite higher aviation fuel prices driving reduced airline capacity. Growth in the Airport’s property portfolio helped offset lower passenger and aeronautical income.

Infratil’s radiology businesses reported mixed results. RHCNZ Medical Imaging, the largest private medical imaging provider in NZ and is 57% owned by Infratil, reported largely flat EBITDAF of $61 million.

The Australian Qscan – which Infratil holds a 59.5% stake in – reported a half-year EBITDAF of A$39 million (NZ$47.8 million), down A$4 million (NZ$4.9 million) from the prior corresponding half-year period last year.

Infratil said the sale of Qscan is still in progress and there’s potential for “another NZ$1 billion or more of divestments over the medium term.”

Infratil updated its full-year guidance for its financial results for the 12 months to March 31 on Wednesday, following the release of its half-year results.

New FY27 guidance:

  • FY27 Proportionate operational EBITDAF guidance increased to NZ$1.370 billion to NZ$1.440 billion, up from Investor Day (NZ$1.320b–$1.420b) and May (NZ$1.300b–$1.400b)
  • Corporate costs of NZ$150 million to $170 million - unchanged
  • Proportionate development spend of NZ$95 million to $110 million - unchanged

Guidance updates at a portfolio company level included:

  • CDC FY27 EBITDAF of A$730m to $770m, increased from $710m to $750m
  • One NZ FY27 EBITDAF of NZ$610m to $640m, narrowed from $600m to $640m
  • Qscan FY27 EBITDAF of A$75m to $85m, decreased from $90m to $105m

Infratil also confirmed on Wednesday it will pay a partially imputed interim dividend of 7.4 cents per share on December 21. The dividend reinvestment plan (DRP) will operate for the interim dividend, with a 2% discount applied to the DRP strike price.

Shares in Infratil, which is listed on the NZX, were up 3.8% to $13.70 in mid-morning trading.

We welcome your comments below. If you are not already registered, please register to comment

Remember we welcome robust, respectful and insightful debate. We don't welcome abusive or defamatory comments and will de-register those repeatedly making such comments. Our current comment policy is here.